| Literature DB >> 25250638 |
Abstract
AIMS: To make a comparative evaluation of the effects of different stabilizers and freezing rates on structurally different viruses during lyophilization and storage. METHODS ANDEntities:
Keywords: animal virus lyophilization; animal virus preservation; freezing rate; stabilizer; virus structure
Mesh:
Substances:
Year: 2014 PMID: 25250638 PMCID: PMC7166340 DOI: 10.1111/jam.12654
Source DB: PubMed Journal: J Appl Microbiol ISSN: 1364-5072 Impact factor: 3.772
Effects of stabilizers and freezing rates on virus titre reduction (Δ lg TCID50) after lyophilization and 8 months’ storage at 4°C
| Virus | Titre ( | Titre reduction: After lyophilization/in storage duration only (after lyophilization and storage) (Δ | |||||
|---|---|---|---|---|---|---|---|
| Freezing −80°C | Freezing N2 | ||||||
| Stabilizer 1 | Stabilizer 2 | Stabilizer 3 | Stabilizer 1 | Stabilizer 2 | Stabilizer 3 | ||
| Coronaviridae | |||||||
| TGEV | 7·5 | 0·6/2·2 (2·8) | 0·8/1·6 (2·4) | 1·4/1·4 (2·8) | 1·0/2·4 (3·4) | 0·4/2·0 (2·4) | 1·4/1·6 (3·0) |
| BCoV | 6·3 | 1·0/1·0 (2·0) | 1·0/1·0 (2·0) | 1·6/0·8 (2·4) | 0·8/1·4 (2·2) | 0·8/1·2 (2·0) | 1·2/1·4 (2·6) |
| Herpesviridae | |||||||
| BoHV‐1 | 7·9 | 0·8/0·4 (1·2) | 0·0/0·8 (0·8) | 0·6/0·4 (1·0) | 0·8/0·4 (1·2) | 0·2/0·6 (0·8) | 0·2/0·6 (0·8) |
| CaHV‐1 | 2·9 | 1·0/0·2 (1·2) | 0·2/0·4 (0·6) | 0·4/0·2 (0·6) | 1·2/0·2 (1·4) | 0·2/0·2 (0·4) | 0·6/0·4 (1·0) |
| Paramyxoviridae | |||||||
| BPIV‐3 | 8·5 | 1·4/0·4 (1·8) | 0·8/0·4 (1·2) | 0·6/1·6 (2·2) | 1·8/0·2 (2·0) | 0·4/0·6 (1·0) | 0·8/1·4 (2·2) |
| CPIV | 5·5 | 1·6/0·0 (1·6) | 0·6/0·4 (1·0) | 0·4/1·6 (2·0) | 1·0/0·4 (1·4) | 0·2/0·6 (0·8) | 0·4/1·0 (1·4) |
| Adenoviridae | |||||||
| BAdV | 5·3 | 0·6/0·0 (0·6) | 0·4/0·0 (0·4) | 0·6/−0·2 (0·4) | 1·0/−0·4 (0·6) | 0·2/−0·2 (0·0) | 0·6/−0·4 (0·2) |
| CAdV‐1 | 7·5 | 0·8/−0·8 (0·0) | 0·4/−0·2 (0·2) | 0·6/−0·8 (−0·2) | 0·8/−0·6 (0·2) | 0·6/−0·4 (0·2) | 0·8/−0·6 (0·2) |
| Caliciviridae | |||||||
| FCV CAPM V‐238 | 8·3 | 0·2/1·0 (1·2) | 0·0/1·2 (1·2) | 0·0/1·0 (1·0) | 0·2/0·4 (0·6) | 0·4/0·8 (1·2) | 0·0/0·6 (0·6) |
| FCV CAPM V‐254 | 8·1 | 0·2/0·8 (1·0) | 0·2/1·0 (1·2) | 0·2/0·4 (0·6) | 0·4/0·8 (1·2) | 0·2/1·4 (1·6) | 0·4/0·6 (1·0) |
| Picornaviridae | |||||||
| PTV | 7·9 | 3·2/1·0 (4·2) | 4·2/0·6 (4·8) | 3·2/1·0 (4·2) | 2·6/0·4 (3·0) | 3·6/0·4 (4·0) | 3·0/0·8 (3·8) |
| BEV | 6·5 | 2·4/1·4 (3·8) | 3·6/1·2 (4·8) | 3·2/0·6 (3·8) | 2·0/1·4 (3·4) | 3·6/0·6 (4·2) | 2·8/0·8 (3·6) |
Stabilizer 1: culture medium (DMEM, 3% foetal bovine serum) without additives.
Stabilizer 2: culture medium, 2·5% gelatine and 3·5% sucrose.
Stabilizer 3: culture medium, 10% skim milk and 1% sodium glutamate.
Relationship between TCID50 reduction and virus structure
| Virus family | Differences in titre reductions between virus families: | |||||
|---|---|---|---|---|---|---|
| Coronaviridae | Herpesviridae | Paramyxoviridae | Adenoviridae | Caliciviridae | Picornaviridae | |
| Coronaviridae | */**(**) | NS/**(**) | NS/**(**) | **/**(**) | **/**(**) | |
| Herpesviridae | */**(**) | NS/NS(**) | NS/**(**) | NS/NS(NS) | **/NS(**) | |
| Paramyxoviridae | NS/**(**) | NS/NS(**) | NS/**(**) | **/NS(*) | **/NS(**) | |
| Adenoviridae | NS/**(**) | NS/**(**) | NS/**(**) | NS/**(**) | **/**(**) | |
| Caliciviridae | **/**(**) | NS/NS(NS) | **/NS(*) | NS/**(**) | **/NS(**) | |
| Picornaviridae | **/**(**) | **/NS(**) | **/NS(**) | **/**(**) | **/NS(**) | |
NS, nonsignificant differences.
Differences between virus families in titre reduction after lyophilization and 8 months’ storage at 4°C with different stabilizers and freezing rates. Four‐factor partly nested anova followed by Tukeyʼs post hoc test: *, **significant differences (P ≤ 0·05 and P ≤ 0·01, respectively).
Efficiency of stabilizers and freezing rates within virus families
| Virus family | Lyophilization | Storage | Lyophilization and storage | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Stabilizer efficiency | Freezing rate efficiency | Within‐family virus difference | Stabilizer efficiency | Freezing rate efficiency | Within‐family virus difference | Stabilizer efficiency | Freezing rate efficiency | Within‐family virus difference | |
| Coronaviridae | 1=2 ˃ 3 | N2 = −80°C | NS | 1=2=3 | −80 ˃ N2 | ** | 1=2 ˃ 3 | N2 = −80°C | ** |
| Herpesviridae | 2=3 ˃ 1 | N2 = −80°C | NS | 1=2=3 | N2 = −80°C | ** | 2=3 ˃ 1 | N2 = −80°C | NS |
| Paramyxoviridae | 2=3 ˃ 1 | N2 = −80°C | NS | 1=2 ˃ 3 | N2 = −80°C | NS | 2 ˃ 1=3 | N2 = −80°C | ** |
| Adenoviridae | 2 ˃ 1=3 | N2 = −80°C | NS | 1=2=3 | N2 = −80°C | ** | 1=2=3 | N2 = −80°C | NS |
| Caliciviridae | 1=2=3 | N2 = −80°C | NS | 1=2=3 | N2 = −80°C | NS | 1=2=3 | N2 = −80°C | NS |
| Picornaviridae | 1 ˃ 3 ˃ 2 | N2 ˃ −80°C | * | 1=2=3 | N2 = −80 | NS | 1=3 ˃ 2 | N2 ˃ −80°C | NS |
NS, nonsignificant differences.
Stabilizers 1, 2 and 3 (see Materials and methods and Table 1 for stabilizer composition) and freezing rates N2 and −80°C ordered by efficiency (better than ˃ , equal=) on the basis of three‐factor anova, post hoc Tukeyʼs test with differences considered significant at P ≤ 0·05.
Differences in titre reduction between two viruses in each virus family evaluated on the basis of three‐factor anova: *, ** ‐ significant differences (P ≤ 0·05 and P ≤ 0·01, respectively).
The effect of lyophilization with different stabilizers and freezing rates on morphology and infectious titre of enveloped viruses
| Virus | Treatment | Intact viral particles | Visibly disrupted envelops | Naked capsids | Residual titre | |
|---|---|---|---|---|---|---|
| TGEV | Fresh | – | 47 | 53 | – | 100 |
| Lyophilized | −80°C, stabilizer 1 | 40 | 60 | – | 25 | |
| Lyophilized | −80°C, stabilizer 2 | 38 | 62 | – | 16 | |
| Lyophilized | −80°C, stabilizer 3 | 39 | 61 | – | 4 | |
| Lyophilized | N2, stabilizer 1 | 35 | 65 | – | 10 | |
| Lyophilized | N2, stabilizer 2 | 48 | 52 | – | 40 | |
| Lyophilized | N2, stabilizer 3 | 36 | 64 | – | 4 | |
| BoHV‐1 | Fresh | – | 43 | 44 | 13 | 100 |
| Lyophilized | −80°C, stabilizer 1 | 15 | 55 | 30 | 16 | |
| Lyophilized | −80°C, stabilizer 2 | 39 | 42 | 19 | 100 | |
| Lyophilized | −80°C, stabilizer 3 | 30 | 50 | 20 | 25 | |
| Lyophilized | N2, stabilizer 1 | 11 | 55 | 34 | 16 | |
| Lyophilized | N2, stabilizer 2 | 39 | 43 | 18 | 63 | |
| Lyophilized | N2, stabilizer 3 | 28 | 54 | 18 | 63 | |
| BPIV‐3 | Fresh | – | 86 | 11 | 3 | 100 |
| Lyophilized | −80°C, stabilizer 1 | 29 | 29 | 42 | 4 | |
| Lyophilized | −80°C, stabilizer 2 | 39 | 39 | 22 | 16 | |
| Lyophilized | −80°C, stabilizer 3 | 27 | 53 | 20 | 25 | |
| Lyophilized | N2, stabilizer 1 | 17 | 34 | 49 | 2 | |
| Lyophilized | N2, stabilizer 2 | 34 | 38 | 28 | 40 | |
| Lyophilized | N2, stabilizer 3 | 39 | 40 | 13 | 16 | |
Descriptions of each stabilizer composition (1, 2 and 3) appear in the Material and methods section and explanations together with Table 1.
Results obtained from transmission electron microscopy of 200 viral particles.
Data transformed from ∆ lg TCID50 as: .
Figure 1TEM micrographs (magnification 140 000–180 000×) of representative viral particles in the morphology classes related to the data in Table 4, summarizing morphological changes in viral envelopes after lyophilization. (a) full TGEV particle; (b) two disintegrating TGEV particles; (c) BoHV‐1 enveloped particles: with (arrow) and without visible disruption in glycoprotein membrane; (d) a naked BoHV‐1 nucleocapsid; (e) an intact BPIV‐3 particle; (f) a particle of BPIV‐3 with disrupted membrane and releasing nucleocapsid; (g) a cluster of naked BPIV‐3 nucleocapsids.
Figure 2SEM micrographs (magnification 150×) of cross sections of lyophilized stabilizers at two freezing rates. (a, b) Freeze‐dried matrix of stabilizer 1: DMEM, 3% foetal bovine serum without additive, frozen at −80°C and in liquid nitrogen, respectively; (c, d) matrix of stabilizer 2: DMEM, 3% foetal bovine serum, 2·5% gelatine and 3·5% sucrose, frozen at −80°C and in liquid nitrogen, respectively; (e, f) matrix of stabilizer 3: DMEM, 3% foetal bovine serum, 10% skim milk a 1% sodium glutamate, frozen at −80°C and in liquid nitrogen, respectively.